External Source

Optimismm: Benefits Of A New Triplet Therapy For Mm Patients Relapsing On Lenalidomide

2018 1:43
Synopsis
Meletios Dimopoulos, MD, of the University of Athens School of Medicine, Athens, Greece, gives an overview of the OPTIMISMM ...

You Might Also Like

OPTIMISMM: investigating an alternative therapy for lenalidomide-refractory patients 4:58
Optimismm: Investigating An Alternative Therapy For Lenalido...
2018
OPTIMISMM trial for refractory multiple myeloma 5:35
Optimismm Trial For Refractory Multiple Myeloma
2018
Choosing Triplet Therapy at Myeloma Relapse 6:46
Choosing Triplet Therapy At Myeloma Relapse
2017
Switching IMiDs: The OPTIMISMM Trial’s Impact on MM 3:59
Switching Imids: The Optimismm Trial’s Impact On Mm
2018
Alternative options for MM patients relapsing under lenalidomide 1:43
Alternative Options For Mm Patients Relapsing Under Lenalido...
2018
OPTIMISMM study update 2:59
Optimismm Study Update
2020
Dr. Landgren on Daratumumab Triplet in Relapsed Myeloma 1:26
Dr. Landgren On Daratumumab Triplet In Relapsed Myeloma
2017
Triplet Regimens With Pomalidomide in Patients With Multiple Myeloma 1:16
Triplet Regimens With Pomalidomide In Patients With Multiple...
2018
Pomalidomide + Low-Dose Dex + Dara in Relapsed and/or Refractory Multiple Myeloma 4:01
Pomalidomide + Low-dose Dex + Dara In Relapsed And/or Refrac...
2018
Multiple Myeloma: Triplet Therapy in Later-Line Settings 7:54
Multiple Myeloma: Triplet Therapy In Later-line Settings
2015
Dr. Fonseca on FDA Approval of Daratumumab Triplets in Multiple Myeloma 0:59
Dr. Fonseca On Fda Approval Of Daratumumab Triplets In Multi...
2016
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.